Your session is about to expire
← Back to Search
Cooling Device for Kidney Complication (QuitWIT Trial)
QuitWIT Trial Summary
This trial is testing a cooling device that may help prevent damage to transplanted kidneys by keeping temperatures at or below 5°C for at least 60 minutes.
QuitWIT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowQuitWIT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.QuitWIT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had a kidney transplant in the past.I am a donor after my heart has stopped.I am 18 years old or older.I am scheduled to receive an organ transplant from a deceased donor.I have given my consent for the transplant surgery.
- Group 1: Surgery utilizing the Kidney Skinn cooling device
- Group 2: Standard transplant surgery practice
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants can the research team accommodate for this experiment?
"Confirmed. The trial's record on clinicaltrials.gov reveals that the study is presently recruiting new participants to join and began accepting applications since February 4th, 2022. 45 people are needed across 1 site for a satisfactory test sample size."
Are any new participants still being sought for this research study?
"As of this moment, clinicaltrials.gov is advertising for patients to participate in a medical study that was initially posted on February 4th 2022 and revised two months later in April 19th 2021."
What are the underlying goals of this investigation?
"This 6-month long trial seeks to evaluate the impact of Kidney Skinn cooling device versus usual care on warm ischemia time during kidney transplantation. Secondary objectives include assay of renal allograft surface & core temperature, serum creatinine levels at discharge from initial hospitalization for transplantation, and comparison between intervention & control arms in terms of biomarkers related to ischemia-reperfusion injury (KIM-1/NGAL/TNFR1/MCP-1/suPAR/YKL 40)."
Share this study with friends
Copy Link
Messenger